Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-κB signaling in HER2-overexpressing breast cancer cells

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3301-3313

  Seo, Hye Sook ^a   Choi, Han Seok ^a   Choi, Hyeong Sim ^a   Choi, Youn Kyung ^a   Um, Jae Young ^a   Choi, Inhwa ^a   Shin, Yong Cheol ^a   Ko, Seong Gyu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Apoptosis; Breast cancer; Genistein; NF B; Quercetin

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENISTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHYTOESTROGEN; PROTEIN P53; QUERCETIN; STAT3 PROTEIN; SYNAPTOTAGMIN I;

APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENISTEIN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOCHONDRIA; MODELS, BIOLOGICAL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHYTOESTROGENS; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80054754782     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Zhang A, Wu Y, Lai HWL and Yew DT: Apoptosis - a brief review. Neuroembryology 3: 47-59, 2004.
2. Kolb TM, Chang SH and Davis MA: Biochemical and morphological events during okadaic acid-induced apoptosis of Tsc2-null ERC-18 cell line. Toxicol Pathol 30: 235-246, 2002. (Pubitemid 34293048)
3. Waring P and Mullbacher A: Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol 77: 312-317, 1999. (Pubitemid 29370101)
4. Gupta S: Molecular signaling in death receptor and mitochondrial pathways of apoptosis (review). Int J Oncol 22: 15-20, 2003.
5. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998. (Pubitemid 28406816)
6. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274: 22932-22940, 1999.
7. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998. (Pubitemid 28391864)
8. Sirtori CR, Arnoldi A and Johnson SK: Phytoestrogens: End of a tale? Ann Med 37: 423-438, 2005. (Pubitemid 41476128)
9. Mense SM, Hei TK, Ganju RK and Bhat HK: Phytoestrogens and breast cancer prevention: Possible mechanisms of action. Environ Health Persp 116: 426-433, 2008. (Pubitemid 351864298)
10. Velentzis LS, Woodside JV, Cantwell MM, Leathem AJ and Keshtgar MR: Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer 44: 1799-1806, 2008.
11. Duffy C and Cyr M: Phytoestrogens: Potential benefits and implications for breast cancer survivors. J Womens Health (Larchmt) 12: 617-631, 2003. (Pubitemid 37266005)
12. Duffy C, Perez K and Partridge A: Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin 57: 260-277, 2007. (Pubitemid 47620124)
13. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL and Clinton SK: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129: 1628-1635, 1999. (Pubitemid 29406613)
14. de Souza PL, Russell PJ, Kearsley JH and Howes LG: Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. Nutr Rev 68: 542-555, 2010.
15. Toyomura K and Kono S: Soybeans, soy foods, isoflavones and risk of colorectal cancer: A review of experimental and epidemiological data. Asian Pac J Cancer Prev 3: 125-132, 2002.
16. Singh AV, Franke AA, Blackburn GL and Zhou JR: Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 66: 1851-1858, 2006. (Pubitemid 43259972)
17. Pavese JM, Farmer RL, and Bergan RC: Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metast Rev 29: 465-482, 2010.
18. Verma AK, Johnson JA, Gould MN and Tanner MA: Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48: 5754-5758, 1988.
19. Spevak CC, Park EH, Geballe AP, Pelletier J and Sachs MS: Her-2 upstream open reading frame effects on the use of downstream initiation codons. Biochem Bioph Res Co 350: 834-841, 2006. (Pubitemid 44739923)
20. Nielsen DL, Andersson M and Kamby C: HER2-targeted therapy in breast cancer. monoclonal antibodies and tyrosine kinase inhibitors. Cancer Treat Rev 35: 121-136, 2009.
21. Menard S and Pupa SM, Campiglio M and Tagliabue E: Biologic and therapeutic role of HER2 in cancer. Oncogene 22: 6570-6578, 2003. (Pubitemid 37372337)
22. Lipton A, Ali SM, Leitzel K, Demers L, Chinchilli V, Engle L, Harvey HA, Brady C, Nalin CM, Dugan M, Carney W and Allard J: Elevated serum her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin Oncol 20: 1467-1472, 2002. (Pubitemid 34260524)
23. Tokunaga E, Oki E, Nishida K, Koga T, Egashira A, Morita M, Kakeji Y and Maehara Y: Trastuzumab and breast cancer: Developments and current status. Int J Clin Oncol 11: 199-208, 2006. (Pubitemid 44087118)
24. Dean-Colomb W and Esteva FJ: Her2-positive breast cancer: Herceptin and beyond. Eur J Cancer 44: 2806-2812, 2008.
25. Shin I and Arteaga CL: Expression of active akt protects against tamoxifen-induced apoptosis in MCF-7 cells. IUBMB Life 58: 664-669, 2006. (Pubitemid 44691469)
26. Jänicke RU: MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Tr 117: 219-221, 2009.
27. Sakla MS, Shenouda NS, Ansell PJ, Macdonald RS and Lubahn DB: Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells. Endocrine 32: 69-78, 2007. (Pubitemid 350242549)
28. Schuler M and Green DR: Mechanisms of p53-dependent apoptosis. Biochem Soc T 29: 684-688, 2001. (Pubitemid 33131760)
29. Shen Y and White E: P53-dependent apoptosis pathways. Adv Cancer Res 82: 55-84, 2001. (Pubitemid 32613382)
30. Stiewe T and Putzer BM: Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 26: 464-469, 2000.
31. Polager S and Ginsberg D: p53 and E2f: Partners in life and death. Nat Rev Cancer 9: 738-748, 2009.
32. Adams JM and Cory S: The bcl-2 protein family: Arbiters of cell survival. Science 281: 1322-1326, 1998. (Pubitemid 28406819)
33. de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ, Levy DE, Depinho RA and Bonni A: Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Gene Dev 22: 449-462, 2008. (Pubitemid 351272753)
34. Lewis HD, Winter A, Murphy TF, Tripathi S, Pandey VN and Barton BE: STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: Differential activity between 5′ and 3′ ends. Mol Cancer Ther 7: 1543-1550, 2008.
35. Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J and Jove R: Resveratrol inhibits src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5: 621-629, 2006.
36. Sobey CG, Weiler JM, Boujaoude M and Woodman OL: Effect of short-term phytoestrogen treatment in male rats on nitric oxide-mediated responses of carotid and cerebral arteries: Comparison with 17beta-estradiol. J Pharmacol Exp Ther 310: 135-140, 2004. (Pubitemid 38812704)
37. Woodman OL, Missen MA and Boujaoude M: Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol 44: 155-163, 2004. (Pubitemid 38982157)
38. Desdouets C, Matesic G, Molina CA, Foulkes NS, Sassone-Corsi P, Brechot C and Sobczak-Thepot J: Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol 15: 3301-3309, 1995.
39. Nyormoi O and Bar-Eli M: Transcriptional regulation of metastasis-related genes in human melanoma. Clin Exp Metastas 20: 251-263, 2003. (Pubitemid 36513229)
40. Aggarwal S, Kim SW, Cheon K, Tabassam FH, Yoon JH and Koo JS: Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol Biol Cell 17: 566-575, 2006. (Pubitemid 43191093)
41. McCauslin CS, Heath V, Colangelo AM, Malik R, Lee S, Mallei A, Mocchetti I and Johnson PF: CAAT/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system. J Biol Chem 281: 17681-17688, 2006. (Pubitemid 44035566)
42. Xiang H, Wang J and Boxer LM: Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous bcl-2 expression and apoptosis in murine B cells. Mol Cell Biol 26: 8599-8606, 2006. (Pubitemid 44748591)
43. Mayr B and Montminy M: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609, 2001. (Pubitemid 33674011)
44. Shaywitz AJ and Greenberg ME: CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68: 821-861, 1999. (Pubitemid 29449210)
45. Sárvári M, Szego EM, Barabás K, Jávor A, Tóth S, Kovács Z, and Abrahám IM: Genistein induces phosphorylation of cAMP response element-binding protein in neonatal hypothalamus in vivo. J Neuroendocrinol 21: 1024-1028, 2009.
46. Tolaney SM and Krop IE: Mechanisms of trastuzumab resistance in breast cancer. Anticancer Agents Med Chem 9: 348-355, 2009.
47. Buzdar AU: Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer. Ann Oncol 20: 993-999, 2009.